UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Shareholders Equity (Quarterly): 9.597B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.597B |
| June 30, 2024 | 9.597B |
| December 31, 2023 | 9.921B |
| June 30, 2023 | 9.827B |
| June 30, 2023 | 9.827B |
| December 31, 2022 | 9.720B |
| June 30, 2022 | 9.315B |
| June 30, 2022 | 9.315B |
| December 31, 2021 | 9.495B |
| June 30, 2021 | 9.129B |
| June 30, 2021 | 9.129B |
| December 31, 2020 | 8.943B |
| June 30, 2020 | 7.977B |
| June 30, 2020 | 7.977B |
| December 31, 2019 | 7.885B |
| June 30, 2019 | 7.372B |
| June 30, 2019 | 7.372B |
| December 31, 2018 | 7.218B |
| June 30, 2018 | 6.934B |
| June 30, 2018 | 6.934B |
| December 31, 2017 | 6.974B |
| June 30, 2017 | 6.421B |
| Date | Value |
|---|---|
| June 30, 2017 | 6.421B |
| December 31, 2016 | 5.903B |
| June 30, 2016 | 5.756B |
| June 30, 2016 | 5.756B |
| December 31, 2015 | 6.201B |
| June 30, 2015 | 5.921B |
| June 30, 2015 | 5.921B |
| December 31, 2014 | 6.083B |
| June 30, 2014 | 6.562B |
| June 30, 2014 | 6.562B |
| December 31, 2013 | 6.149B |
| June 30, 2013 | 5.860B |
| June 30, 2013 | 5.860B |
| December 31, 2012 | 6.068B |
| June 30, 2012 | 5.917B |
| June 30, 2012 | 5.917B |
| December 31, 2011 | 6.087B |
| June 30, 2011 | 6.879B |
| December 31, 2010 | 6.105B |
| June 30, 2010 | 5.741B |
| December 31, 2009 | 6.313B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.885B
Minimum
Dec 2019
9.921B
Maximum
Dec 2023
9.177B
Average
9.315B
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Galapagos NV | 3.197B |
| Mithra Pharmaceuticals SA | -9.487M |
| Nyxoah SA | 116.95M |
| Celyad Oncology SA | 1.107M |
| MDxHealth SA | 16.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.75B |
| Total Liabilities (Quarterly) | 7.156B |
| Debt to Equity Ratio | 0.3178 |
| Current Ratio | 1.187 |
| Net Debt Paydown Yield | -0.11% |